Starpharma's dendrimer technology can create precisely-defined synthetic complex macromolecules that are applicable to a wide range of medical uses. Traditionally, "well defined" complex macromolecules such as proteins were largely found only in natural systems.
One important property of dendrimers is “polyvalency” or the presence of multiple active groups on the surface of the dendrimer. This is significant because simultaneous presentation of active groups can yield entirely new or enhanced activity compared to single presentation of the same active group.
The properties of Starpharma’s polylysine dendrimers make them suitable for pharmaceutical applications. For example, they are well defined chemical entities, which simplifies the regulatory process for their approval. They are also "biofriendly", being made predominantly from the amino acid, lysine.